Comparer des méthodes

	Questionnaire de sensibilisation à l'hypoglycémie de Clarke	AGHDA : Évaluation du déficit en hormone de croissance chez l'adulte
Domaine	Endocrinologie	Endocrinologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	1995	2000
Auteur d'origine	William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick	Anthony Hunt, Garry Werther, Peter Wrightson
Type	Patient self-report questionnaire	Patient self-report questionnaire
Source fondatrice	Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
Alias	HAQ, Clarke HAQ, Hypoglycemia Awareness Scale	AGHDA-25
Apparentées	3	3
Résumé	The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.